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Summary 
A panel of 28 monoclonal antibodies (MAb) against the structural proteins of 
murine hepatitis virus-4, strain JHM (MHV-4) was used in three antigen binding 
assays to determine the extent of antigenic homology among six strains of murine 
coronaviruses. The antigenic determinants tudied were highly conserved on the El 
glycoproteins and nucleocapsid (N) proteins of all strains tested. In contrast, 
antigenic polymorphism was observed among the E2 glycoproteins. Of three previ- 
ously described antigenic determinants against which neutralizing antibodies are 
directed, only one, termed A(E2), was conserved on all strains. Antigenic site.B(E2) 
was found only on the strongly neurotropic MHV4 and site C(E2) was present on 
the virulent MHV4 and MHV-3 (hepatotropic) strains, but absent on the weakly 
pathogenic MHV-A59, MHV-1 and MHV-S strains. Four non-neutralizing antibod- 
ies against at least one topographically distinct antigenic determinant, which we 
previously designated D(E2), gave binding patterns consistent with two distinct sites. 
One of these was present on all MHV strains tested and the other was present on all 
strains except MHV-S. These non-neutralizing antigenic sites were redesignated 
E(E2) and D(E2) respectively. 
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Murine hepatitis viruses (MHV) are coronaviruses which cause a variety of 
diseases uch as hepatitis, gastroenteritis and encephalomyelitis (Siddell et al., 1983a, 
1983b; Wege et al., 1982) in the natural host. Despite these variations in pathogene- 
sis, the viruses are closely related in structure and in their mode of replication. Viral 
RNA is complexed with N protein (& = 56-60~) and the envelope is studded 
with petal-shaped peplomers composed of a major glycoprotein, E2 (M, 180-200 000) 
made up of two nonidentical 90000 dalton subunits. A second glycoprotein, El 
(M, = 23-25 000), spans the membrane and interacts internally with the viral RNA. 
El may determine the intracellular site of virus maturation (Siddell et al., 1982; 
Sturman and Holmes, 1983). 
RNA homologies between strains of MHV with different virulence characteristics 
and organ tropisms have been analyzed. Oligonucleotide fingerprinting analysis of 
the highly virulent hepatotropic strain MHV-3 and the weakly pathogenic MHV-A59 
strain revealed structural differences in the genes coding for the RNA polymerase 
and the E2 glycoprotein (Lai et al., 1981). In similar analyses with other strains, each 
MHV isolate yielded a unique oligonucleotide pattern. The neurotropic MHV-4 
strain showed the highest degree of difference among the strains tested, which also 
included MHV-2, 3 and A59 (Wege et al., 1981; Weiss and Leibowitz, 1983). 
Hybridization studies with cDNA clones of the viral RNAs revealed extensive 
nucleic acid homologies between MHV strains (Cheley et al., 1981; Weiss and 
Leibowitz, 1983). More recently sequence analyses of the N gene indicated an overall 
94% homology between the strongly neurotropic MHV-4 and the weakly neurotropic 
MHV-A59 (Armstrong et al., 1983; Skinner and Siddell, 1983). 
Antigen& homologies were initially probed in cross-neutralization assays (Hier- 
holzer et al., 1979; Taguchi et al., 1982; Wege et al., 1981) and neutralization kinetics 
(Childs et al., 1983). These studies showed that MHV strains could be distinguished, 
but that significant levels of cross-reactivity occurred. Strains MHV-2 and 4 were 
closely related, as were strains MHV-1, 3, S and A59. There was no correlation 
between serological typing and virulence. These neutralization assays likely mea- 
sured antigenic homologies at the level of the E2 glycoprotein, which is the target for 
neutralizing antibodies (Collins et al., 1982; Fleming et al., 1983). Tryptic maps of 
the N proteins from five MHV strains also showed a strong level of similarity 
(Cheley et al., 1981). Recently, antigen&c relationships among eleven MHV isolates 
were probed in radioi~unoassays with monoclonal antibodies to MHV4 (Fleming 
et al., 1983). Extensive antigenic variation of the E2 glycoprotein was observed but a 
correlation was drawn between less extensive variations in the N protein and 
pathogenicity. El glycoprotein was markedly conserved among the MHV isolates 
tested. 
MHV-4 is a useful animal model for virus-induced primary demyelination (Haspel 
et al., 1978; Knobler et al., 1981a, 1982; Lampert et al., 1973; Nagashima et al., 
1978; Sorensen et al., 1980; Stohlman and Weiner, 1981; Weiner, 1973). Rapidly 
fatal encephalitis normally masks the more slowly developing demyelinating disease 
in mice (Knobler et al., 1981b; Stohlman and Weiner, 1981; Weiner, 1973). How- 
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ever, infection with mutants or variants of MHV-4 results in survival with accompa- 
nying primary demyelination, due to infection of the oligodendrocyte (Haspel et al., 
1978; Stohlman et al., 1982; Knobler et al., 1982). Monoclonal antibodies (MAb) to 
MHV4 structural proteins were raised and characterized as described previously 
(Collins et al., 1982). A minimum of four topographically distinct antigenic determi- 
nants on E2 and two on El were mapped by competition binding assays (Talbot et 
al., 1984a). At least two distinct antigenic determinants were mapped on the N 
protein (Talbot et al., 1985). Antibodies to sites A, B and C(E2) were capable of 
neutralizing viral infectivity in vitro and passive antibody transfer experiments 
showed that neutralizing antibodies to sites A and B(E2) but not C(E2) could protect 
mice from a lethal intracerebral virus challenge. Such antibodies modulated disease 
from fatal encephalitis to sublethal demyelination (Buchmeier et al., 1984). In the 
present study, we have used a panel of eighteen MAb to MHV4 generated in our 
laboratory and an independently derived panel of ten additional MAb to E2 raised 
by Fleming et al. (1983) to analyze antigenic relationships among six MHV strains 
differing in virulence and organ tropism. These were MHV4 (JHM), both the 
wild-type (wt) strain (Cheever et al., 1949) and the ts8 mutant (Haspel et al., 1978); 
MHV-3 (Dick et al., 1956); MHV-A59 (Manaker et al., 1961); MHV-1 (Gledhill and 
Andrewes, 1951); and MHV-S (Rowe et al., 1963). 
Materials and Methods 
Virus and cell culture 
Murine hepatitis virus strains A59, 1 and S were purchased from the American 
Type Culture Collection. Dr. Julian Leibowitz kindly provided strain MHV-3, as 
well as DBT cells. The origin and cultivation of the wt and ts8 strains of MHV4 
was described previously (Haspel et al., 1978). All viruses were plaque purified two 
or three times, propagated and assayed on L-2.4 or DBT cells. 
Monoclonal antibodies 
The generation and characterization of MAb to the structural proteins of MHV-4 
was described previously (Collins et al., 1982; Buchmeier et al., 1984; Talbot et al., 
1984a). In addition to our panel we obtained an independently generated panel of 
ten MAb to the E2 glycoprotein of MHV-JHM kindly supplied by Dr. John 
Fleming, USC Medical School, Los Angeles (Fleming et al., 1983). 
Antigen preparation 
For indirect immunofluorescence, L-2.4 cells grown on coverslips were infected 
with each MHV strain at a MO1 of 0.01-0.5 and fixed in cold acetone when 
extensive syncytia were observed (16-21 h after infection). Antigenic preparations 
for dot immunoblotting and enzyme immunoassays (EIA) consisted of microsomal 
fractions from MHV infected or uninfected control cells, as described previously 
(Talbot et al., 1984a). 
Antigen binding assays 
Indirect immunofluorescence was performed as described previously (Collins et 
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al., 1982) using monoclonal hybridoma cell culture fluids undiluted or after a 
lo-fold concentration in a macrosolute concentrator, type B-15 (Amicon Corp., 
Danvers, MA). The degree of reactivity was scored qualitatively on a scale of 0 to 4 
by comparison with positive and negative controls. Enzyme immunoassays were as 
described previously (Talbot et al., 1984a) except that 200-fold concentrates of tissue 
culture fluids were used (40-fold initial concentration by precipitation with 50% 
(w/w) saturated ammonium sulfate followed by 5-fold additional concentration as 
described above). Viral antigens were in the form of subcellular fractions, hence it 
was necessary to calibrate the amount of protein used for each virus strain. This was 
accomplished by ~determining, in preliminary titrations, the quantity of antigen 
necessary to saturate the binding of an optimal dilution of a mixture of five MAb to 
the highly conserved N protein as previously described (Talbot et al., 1984a). Dot 
immunoblotting assays were performed as previously detailed (Talbot et al., 1984b) 
in a Bio-Dot microfiltration apparatus (Bio-Rad Laboratories, Richmond, Calif.). 
An excess of viral antigen (as determined by enzyme immunoassay) was bound to 
nitrocellulose and reacted with six serial 5-fold dilutions of each MAb culture fluid. 
Bound immunoglobulin was detected by incubation of the 96 well nitrocellulose 
replica in a 150 mm Petri dish with ‘251-labeled, affinity-purified goat antibody to 
mouse immunoglobulin (H + L chain specificity). After autoradiography, radioactiv- 
ity bound on each dot was quantitated by gamma counting, and comparisons were 
made in the linear portion of the antibody binding curves. As with enzyme 
immunoassays, a positive reaction was scored as greater than twice background 
binding, a plus/minus reaction as twice background binding and a negative reaction 
as less than twice background binding. 
Results 
Antigenic relationships among murine coronaviruses 
Indirect immunofluorescence on acetone-fixed cells was initially used to screen 
hybridoma antibodies and proved to be a helpful tool to delineate antigenic 
relationships among MHV strains (Fig. 1). Intense fluorescence staining was seen in 
multinucleated giant cells infected by strains of MHV in which a particular antigenic 
site was conserved. In this example, the variation of the neutralization sites, 
previously assigned to the E2 glycoprotein (Talbot et al., 1984a), is shown for three 
MHV strains. Epitope A(E2), recognized by MAb 5B19.2 was conserved among 
these and all other MHV strains tested. In contrast, epitope B(E2), recognized by 
MAb 5A13.5, was unique to MHV-4. Epitope C(E2) recognized by MAb 4B11.6 was 
observed on MHV4 and MHV-3 but not on the other strains tested. Staining of 
control uninfected cells with these MAb was always at background negative levels. 
A second antigen-binding assay was developed to confirm antigenic relationships 
initially determined by indirect immunofluorescence. We have previously used the 
dot blotting assay to analyze detergent sensitivities of different viral epitopes (Talbot 
et al., 1984b). In the present study, this assay was modified into a solid-phase 
radioimmunoassay using nitrocellulose as an efficient antigen-binding matrix. The 
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Fig. 1. Antigenic variation of neutralization sites on MHV E2 glycoproteins. Monolayers of L-2.4 cells 
were infected with MHV-4 (panels A, D, G), MHV-3 (panels B, E, H) or MHV-A59 (panels C, F, I) at a 
MO1 of 0.01-0.02 for 16 h. Acetone-fixed cells were stained with undiluted hybridoma culture fluids of 
MAb 5B19.2 (panels A-C), 5A13.5 (panels D-F) or 4B11.6 (panels G-I), which are directed against the 
three neutralization sites A, B and C(E2), respectively. Fluorescence staining of syncytia induced by the 
three MHV strains is evident with MAb 5B19.2 whereas MAb 5A13.5 only stained MHV-4 infected cells 
and MAb 4B11.6 only stained MHV-4 and MHV-3 infected cells. Magnification is 250 x 
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assay was very sensitive and quantitative (Jahn et al., 1984; Talbot et al., 1984b), and 
also provided a visual representation of results. Membrane-enriched fractions from 
virus infected cells were used as a source of viral antigens. Indirect immunofluores- 
cence showed extensive antigenic conservation of the N protein among all MHV 
strains tested, hence a pool of five MAb against N was used to standardize the 
protein concentration of each viral antigen preparation. A quantity of viral antigen 
5B19.2 
A t 5B170.3 
B ( 5A13.5 
C { 4B11.6 
E 
5B207.3 
158216.8 
A { 58119.6 
B { 5A5.2 
C i5B128.3 
5811.5 
5B39.1 
A ( 4B6.2 
B 158188.2 
5B145.5 
5886.2 
5B175.5 
E2 
El 
N 
Fig. 2. Antigenic relationships among murine coronaviruses determined by dot immunoblotting. An 
excess of viral antigen was applied to nitrocellulose paper as dots and labeled with MAb culture fluids 
(dilutions 1:5-l : 125). Antigen preparations from control uninfected cells (C) or cells infected with either 
of six MHV strains were used, which were MHV-4 (wt and rsS), MHV-3 (3) MHV-A59 (A59), MHV-1 
(1) or MHV-S (S). The polypeptide specificity of the MAb is indicated on the right and the hybridoma 
designation, as well as the epitope specificity are on the left. Binding of each MAb to viral antigen was 
detected with radiolabeled goat anti-mouse immunoglobulin. 
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determined by enzyme immunoassay to be in excess of that required for maximal 
antibody binding was applied on the nitrocellulose solid support. Serial dilutions of 
MAb culture fluids were then reacted and detected with a radiolabeled second 
antibody. After autoradiography, each dot was cut out and counted for *“I 
radioactivity. Comparisons between antibody binding on viral antigens from differ- 
ent MHV strains were established in the linear portion of the binding curves and the 
results obtained are shown in Fig. 2. Binding of each MAb to control antigen dots 
was negligible (400-500 cpm), whereas pecific binding on viral antigen dots reached 
levels of up to 13 000 cpm. Background binding on MHV-1 was often higher than on 
the other MHV strains (Fig. 2, MAb 5A13.5 and 4B11.6) and this background 
binding was not diluted out with decreasing concentration of antibody. In agreement 
with the results of Fleming et al. (1983), extensive conservation of the El glycopro- 
tein was evident and similar levels of antibody binding were seen on each MHV 
strain, with the exception of the ts8 mutant of MHV-4. Antigenic variation was 
observed in the N protein, particularly with MHV-A59 and MHV-S. However, the 
most extensive polymorphism was seen on the E2 glycoprotein. As was shown by 
indirect immunofluorescence, site A(E2) was conserved among all MHV strains 
tested, whereas site B(E2) was specific for MHV-4 and site C(E2) was specific for 
MHV-4 and MHV-3. Four non-neutralizing MAb directed against at least one 
antigenic site provisionally designated D(E2) (Talbot et al., 1984a) gave two distinct 
binding patterns. MAb 5B21.5 and -5B93.7 reacted with all strains tested except 
MHV-S, whereas MAb 5B207.3 and 5B216.8 reacted with all of the strains we tested. 
Thus, these two pairs of antibodies likely recognize at least two different structures 
on the E2 glycoprotein, which we have redefined D(E2) and E(E2), respectively. 
In order to confirm the antigenic polymorphism observed on the E2 glycoprotein, 
we obtained a panel of MAb against E2 generated independently by Fleming et al. 
(1983), and assayed these antibodies for strain-specific binding in the dot immuno- 
blotting assay described above. Results of such an experiment are shown in Fig. 3. 
Polymorphism similar in extent to that described above was also observed with these 
antibodies. Moreover, similarities in binding patterns emerged between these. two 
panels of MAb. MAb 5.1.2, 5.2.2 and 5.7.2 were similar to our neutralizing MAb 
4B11.6 and 5.7.18 was similar to our 5A13.5. All of these antibodies, except 5.1.2 
neutralized virus in vitro (Fleming et al., 1983; Collins et al., 1982). Non-neutralizing 
antibodies 5.7.1 and 5.1.16 showed a similar binding pattern to that of antibodies 
against nonneutralizing site E (5B207.3 and 5B216.8). The binding pattern of 
antibodies to antigenic site D was not observed with the Fleming panel of antibod- 
ies. Conversely, the specificity patterns of antibodies 5.2.5 and 5.2.6, as well as that 
of 5.7.5 and 5.7.6 were unique to the panel obtained from Fleming. 
A third antigen-binding assay was also used to delineate antigenic relationships. 
An enzyme immunoassay (EIA) which we have previously described (Talbot et al., 
1984a) was applied to the present study. We found EIA to be less sensitive than 
either the immunofluorescence or dot blotting assays when MAb culture fluids were 
used. Thus, it was necessary to concentrate these fluids to be used in EIA. 
Nevertheless, only ten of eighteen MAb could reliably be used in the assay. The 
cumulative results of the EIA are combined with results of the two other antigen- 
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binding assays and presented in Table 1. In dot immunoblotting assays and EIA, a 
positive reaction was scored as greater than twice background binding. A plus or 
minus reaction corresponded to approximately twice background binding and’ a 
negative reaction to less than twice background binding. The results of all three 
antigen binding assays generally agreed, with a few exceptions. For example, EIA 
results were sometimes negative but dot blotting and immunofluorescence results 
scored as positive, such as MAb 5B19.2 and 5B170.3 with MHV-1 and S, MAb 
5B119.6 and 5B11.5 for MHV-1 and MAb 5B188.2 for MHV4 ts8. Similarly, dot 
blotting results could be negative while immunofluorescence was positive, such as 
MAb 5B39.1 and 5B175.5 for MHV4 rs8, MAb 5B145.5 for MHV-A59 and S and 
MAb 4B6.2 for MHV-A59. In the latter case, EIA results were also positive. Such 
discrepancies likely result from differences in assay sensitivity and/or antigen 
stability. 
It is apparent from Table 1 that nearly complete conservation of El glycoprotein 
antigens exists among the six MHV strains tested. Some variation was shown on the 
N protein in agreement with Fleming et al. (1983). Antigenic site A(N) is apparently 
lost on MHV-S and a distinct determinant recognized by MAb 5B175.5 is lost on 
MHV-A59. Extensive antigenic variation is evident on the E2 glycoprotein. The 
three different antigen binding assays confirm conservation of sites A and E(E2) but 
strain variation was observed in sites B, C and D(E2). Site B(E2) was only found on 
the neurotropic strain MHV4, whereas site C(E2) was present on the two virulent 
J.1.2 
J.7.18 
J.2.2 
J.7.2 
J.2.5 
J.2.6 
J.7.1 
J.7.5 
J.7.6 
J.1.16 
J.2.7 
(El) 
Fig. 3. Antigenic variation of the E2 glycoprotein confirmed with a separately generated panel of MAb 
(Fleming et al., 1983). The experiment was performed as described in the legend to Fig. 2. The hybridoma 
designation is on the left. All these MAb were specific to E2, except 5.2.7 which is directed to El. 
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TABLE 1 
SUMMARY OF ANTIGEN BINDING ASSAYS WITH MONOCLONAL ANTIBODIES TO MHV4 
._.__I 
MHV Strain 
-~ ~_~~ ~~~ 
wt ts8 3 A59 1 S 
Hybridoma Epitope 123 123 123 123 123 123 
____ 
5819.2 AIE21 l .e l .m 0.0 l .0 .OC l K 
58119.6 AlElI 0.0 0.0 0.0 l .0 l O@ 0.0 
5A5.2 BlEll 00 00 00 00 l o l o 
58126.3 ClEl) 00 .a 00 a. l o l o 
5811.5 **a **a l *e l eo l .O moo 
5839.1 00 l e l a l O 00 l * 
486.2 AlNl l oe 0.0 ma. 30. 0.0 ooc 
58186.2 BIN1 l .e l ao 0.0 .eo 0.0 ..a 
58145.5 l o *a .a 00 l . 00 
5886.2 l o .a 00 00 00 00 
56175.5 l e 00 00 00 00 00 
strains MHV-4 and -3 but lost on the weakly pathogenic MHV strains A59, 1 and S. 
Finally, site D(E2) was found on all MHV strains tested, with the exception of 
MHV-S. 
Discussion 
28 monoclonal antibodies against the JHM strain of murine hepatitis virus 
(MHV-4) were used in three different antigen binding assays to delineate antigenic 
relationships among the structural proteins of six MHV strains. In agreement with 
studies of Fleming and colleagues (Fleming et al., 1983), we found extensive 
conservation of antigenic determinants on the internal viral protein N, and particu- 
larly on the transmembrane glycoprotein, El. Using eighteen MAb against the 
peplomer glycoprotein, E2 and raised in two laboratories, we found significant 
antigenic polymorphism on this glycoprotein. In contrast to the report of Fleming 
and colleagues (Fleming et al., 1983), we found that antigenic variation of the E2 
glycoprotein was a better correlate of pathogenicity of a given virus strain than was 
variation in the N protein. Variation on E2 has been correlated with previously 
mapped antigenic determinants (Talbot et al., 1984a). Neutralizing antibodies 5A13.5 
and 4B11.6 are directed against two topographically distinct antigenic determinants 
designated B and C(E2), respectively (Talbot et al., 1984a). In separate studies, 
detection of these two determinants was found to be dependent on the native 
conformation of the molecule (Talbot et al., 1984b). In the present study, we found 
minimal conservation of these two antigenic sites in the MHV strains tested: site 
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B(E2) was only recognized on the MHV-4 strain, which is known to be strongly 
neurotropic (Siddell et al., 1983; Wege et al., 1982) and site C(E2) was preserved on 
the two virulent strains MHV4 and MHV-3 but absent on the weakly pathogenic 
strains MHV-A59, MHV-1 and MHV-S. 
A third neutralization site on the MHV4 E2 glycoprotein, designated A(E2), was 
conserved among all MHV strains tested. Separate studies have shown that this site 
is stable to sodium dodecyl sulfate (SDS) denaturation suggesting that it may consist 
of a primary sequence of amino acids (Talbot et al., 1984b) and that the frequency 
of mutation at this site reflected as antibody resistance is very low (data not shown). 
Conservation of this determinant and its resistance to antibody selection may 
indicate a structure that is essential for productive infection. Conservation of site 
A(E2) may account for the reported cross-neutralization between different MHV 
strains (Childs et al., 1983; Hierholzer et al., 1979; Taguchi et al., 1982; Wege et al., 
1981). In other studies (Talbot et al., 1985) we have shown that mice infected with 
MHV-4, A-59, MHV-1 and MHV-S all respond by producing antibody to site 
A(E2). Finally, non-neutralizing sites D and E(E2), which are also stable to SDS 
denaturation (Talbot et al., 1984b), are extensively conserved among MHV strains, 
with the exception of MHV-S which has lost site D(E2). 
In contrast to the small plaque variant of MHV-4 generated by Stohlman and 
colleagues (Stohlman et al., 1982), the ts8 mutant generated by Haspel and col- 
leagues (Haspel et al., 1978) appears to be antigenically indistinguishable from the 
wild-type MHV-4 strain. In our study using three different antigen binding assays, 
we assumed that a positive reaction in any one of the assays was an indication of 
antigenic conservation and that only in those instances where a negative reaction 
was obtained in all assays could we conclude a loss of antigenic determinants. In 
several instances, the importance of using more than one assay is stressed since often 
a positive reaction was found in only one or two assays. 
Our studies use two independently derived panels totaling 28 MAb against the 
structural proteins of MHV4 to analyze antigenic relationships among murine 
hepatitis viruses. In part these studies confirm and extend the studies of Fleming et 
al. (1983) which showed extensive conservation of antigenic determinants on MHV 
El and N proteins and minimal conservation of epitopes on the E2 glycoprotein. 
This report differs from the previously reported studies in that we found a better 
correlation between antigenic variation, organ tropism and virulence at the level of 
the E2 glycoprotein rather than the previously reported correlation in N. This may 
reflect the larger number of E2 antibodies employed in the present study. We have 
also confirmed the identity of each MHV as a separate strain with a distinctive 
mosaic of antigenic markers. More detailed structural studies on E2, its functional 
properties, and interaction(s) with cellular receptors will be helpful to gain a better 
understanding of the molecular basis for coronavirus tropism and virulence. 
Acknowledgements 
This is Publication Number 3513-IMM from the Department of Immunology, 
Scripps Clinic and Research Foundation, La Jolla, Calif. We are grateful to Hanna 
327 
A. Lewicki for expert technical assistance, to Michael B.A. Oldstone for helpful 
discussion and to Gay Wilkins for typing the manuscript. 
This work was supported by U.S. Public Health Service Grants NS-12428 and 
AI-16102 from the National Institutes of Health. P.J.T. was recipient of a Medical 
Research Council of Canada Fellowship during the study and currently is recipient 
of a National Sciences and Engineering Research Council of Canada Scholarship. 
References 
Armstrong, J.A., Smeekens, S. and Rottier, P. (1983) Sequence of the nucleocapsid gene from murine 
coronavirus MHV-A59. Nucleic Acids Res. 11, 883-891. 
Buchmeier, M.J., Lewicki, H.A., Talbot, P.J. and Knobler, R.L. (1984) Murine hepatitis virus-4 (strain 
JHM) - induced neurologic disease is modulated in viva by monoclonal antibody. Virology 132, 
261-270. 
Cheever, F.S., Dan&, J.B., Pappenheimer, A.M. and Bailey, O.T. (1949) A murine virus (JHM) causing 
disseminated encephalomyelitis with extensive destruction of myelin. I. Isolation and biological 
properties. J. Exp. Med. 90, 181-194. 
Cheley, S., Morris, V.L., Cupples, M.J. and Anderson, R. (1981) RNA and polypeptide homology among 
murine coronaviruses. Virology 115, 310-321. 
Childs, J.C., Stohlman, S.A., Kingsford, L. and Russell, R. (1983) Antigenic relationships of murine 
coronaviruses. Arch. Viral. 78, 81-87. 
Collins, A.R., Knobler, R.L., Powell, H. and Buchmeier, M.J. (1982) Monoclonal antibodies to murine 
hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell 
fusion. Virology 119, 358-371. 
Dick, G.W.A., Niven, J.F.S. and Gledhill, A.W. (1956) A virus related to that causing hepatitis in mice 
(MHV). Br. J. Exp. Pathol. 37, 90-98. 
Fleming, J.O., Stohlman, S.A., Harmon, R.C., Lai, M.M.C., Frelinger, J.A. and Weiner, L.P. (1983) 
Antigenic relationships of murine coronaviruses: Analysis using monoclonal antibodies to JHM 
(MHV-4) virus. Virology 131, 296-307. 
Gledhill, A.W. and Andrewes, C.H. (1951) A hepatitis virus of mice. Br. J. Exp. Pathol. 32, 559-568. 
Haspel, M.V., Lampert, P.W. and Oldstone, M.B.A. (1978) Temperature-sensitive mutants of mouse 
hepatitis virus produce a high incidence of demyelination. Proc. Natl. Acad. Sci. U.S.A. 75,4033-4036. 
Hierholzer, J.C., Broderson, J.R. and Murphy, F.A. (1979) New strain of mouse hepatitis virus as the 
cause of lethal enteritis in infant mice. Infect. Immun. 24, 508-522. 
Jahn, R., Schiebler, W. and Greengard, P. (1984) A quantitative dot immunoblotting assay for proteins 
using nitrocellulose membrane filters. Proc. Natl. Acad. Sci. USA 81, 168441687. 
Knobler, R.L., Dubois-Dalcq, M., Haspel, M.V., Claysmith, A., Lampert, P.W. and Oldstone, M.B.A. 
(1981a) Selective localization of wild-type and mutant mouse hepatitis virus (JHM strain) antigens in 
CNS tissue by fluorescence, light and electron microscopy. J. Neuroimmunol. 1, 81-92. 
Knobler, R.L., Haspel, M.V. and Oldstone, M.B.A. (1981b) Mouse hepatitis virus type 4 (JHM 
strain)-induced fatal central nervous system disease. I. Genetic control and the murine neuron as the 
susceptible site of disease. J. Exp. Med. 153, 832-843. 
Knobler, R.L., Lampert, P.W. and Oldstone, M.B.A. (1982) Virus persistence and recurring demyelination 
produced by a temperature-sensitive mutant of MHV4. Nature (London) 298, 279-280. 
Lai, M.M.C., Brayton, P.R., Armen, R.C., Patton, C.D., Pugh, C. and Stohlman, S.A. (1981) Mouse 
hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from 
hepatotropic strain MHV-3. J. Virol. 39, 823-834. 
Lampert, P.W., Sims, J.K. and Kniazeff, A.F. (1973) Mechanism of demyelination in JHM virus 
encephalomyelitis. Acta Neuropathol. 24, 76-85. 
Manaker, R.A., Piczak, C.V., Miller, A.A. and Stanton, M.F. (1961) A hepatitis virus complicating studies 
with mouse leukemia. J. Natl. Cancer Inst. 27, 29-44. 
328 
Nagashima, K., Wege, H., Meyermann, R. and ter Meulen, V. (1978) Coronavirus induced subacute 
demyelinating encephalitis in rats: A morphological analysis. Acta Neuropathol. 44, 63-70. 
Rowe, W.P., Hartley, J.W. and Capps, W.I. (1963) Mouse hepatitis virus infection as a highly contagious, 
prevalent, enteric infection of mice. Proc. Sot. Exp. Biol. Med. 112, 161-165. 
Siddell, S.G., Wege, H. and ter Meulen. V. (1982) The structure and replication of coronaviruses. Curr. 
Top. Microbial. Immunol. 99, 131-163. 
Siddell, S.G., Anderson, R., Cavanagh, D., Fujiwara, K., Klenk, H.D., Macnaughton, M.R., Pensaert, M., 
Stohlman, S.A., Sturman, L. and van der Zeijst, B.A.M. (1983a) Coronaviridae. Intervirology 20, 
181-189. 
Siddell, S., Wege, H. and ter Meulen, V. (1983b) The biology of coronaviruses. J. Gen. Virol. 64, 761-776. 
Skinner, M.A. and Siddell, S.G. (1983) Coronavirus JHM: Nucleotide sequence of the mRNA that 
encodes nucleocapsid protein. Nucleic Acid Res. 11, 5045-5054. 
Sorensen, O., Percy, D. and Dales, S. (1980) In vivo and in vitro models of demyelinating disease. III. 
JHM virus infection of rats. Arch. Neural. 37, 478-484. 
Stohlman, S.A. and Weiner, L.P. (1981) Chronic central nervous system demyelination in mice after JHM 
virus infection. Neurology 31, 38-44. 
Stohlman, S.A., Brayton, P.R., Fleming, J.O., Weiner, L.P. and Lai, M.M.C. (1982) Murine coronaviruses: 
Isolation and characterization of two plaque morphology variants of the JHM neurotropic strain. J. 
Gen. Viral. 63, 265-275. 
Sturman, L.S. and Holmes, K.V. (1983) The molecular biology of coronaviruses. Adv. Virus Res. 28, 
35-112. 
Taguchi. F., Makino, S. and Fujiwara, K. (1982) Antigenic differentiation of mouse hepatitis viruses by 
neutralization tests. Microbial. Immunol. 26. 741-745. 
Talbot, P.J., Salmi, A.A., Knobler, R.L. and Buchmeier, M.J. (1984a) Topographical mapping of epitopes 
on the glycoproteins of murine hepatitis virus-4 (strain JHM): Correlation with biological activities. 
Virology 132, 250-260. 
Talbot, P.J., Knobler. R.L. and Buchmeier, M.J. (1984b) Western and dot immunoblotting analysis of 
viral antigens and antibodies: Application to murine hepatitis virus. J. Immunol. Methods 73, 
177-188. 
Talbot, P.J., Salmi, A.A., Knobler, R.L. and Buchmeier, M.J. (1985) Epitope-specific antibody response to 
murine hepatitis virus-4 (strain JHM). J. Immunol. 134, 1217-1224. 
Wege, H., Stephenson, J.R., Koga, M., Wege, H. and ter Meulen, V. (1981) Genetic variation of 
neurotropic and non-neurotropic murine coronaviruses. J. Gen. Virol. 54, 67-74. 
Wege. H.. Siddell, S. and ter Meulen. V. (1982) The biology and pathogenesis of coronaviruses. Curr. Top. 
Microbial. Immunol. 99, 165-200. 
Weiner, L.P. (1973) Pathogenesis of demyelination induced by mouse hepatitis virus (JHM virus). Arch. 
Neurol. 28, 298-303. 
Weiss, S.R. and Leibowitz, J.L. (1983) Characterization of murine coronavirus RNA by hybridization 
with virus-specific cDNA probes. J. Gen. Viral. 64, 127-133. 
(Manuscript received 24 September 1984) 
